Anticoagulant News and Research RSS Feed - Anticoagulant News and Research

Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Researchers from the University of Arkansas for Medical Science (USA), in collaboration with University Hospital Frankfurt and University Hospital Dresden, under the supervision of Prof. Vladimir Zharov and with the participation of Alexander Melerzanov, the dean of Department of Biological and Medical Physics (MIPT), conducted experiments on mice to detect blood clotting using photoacoustic flow-cytometry. [More]
Inhealthcare introduces first self-testing mobile app for warfarin users

Inhealthcare introduces first self-testing mobile app for warfarin users

Digital health specialist Inhealthcare is bringing to market the first self-testing mobile app for warfarin users that connects directly to doctors. [More]
Clinical review of patients with atrial fibrillation prevents hundreds of strokes, saves NHS millions of pounds

Clinical review of patients with atrial fibrillation prevents hundreds of strokes, saves NHS millions of pounds

A review of 135,000 patients with atrial fibrillation (AF) at more than a 1,000 GP practices led to over 25,000 medical interventions, which is believed to have prevented hundreds of strokes and saved the NHS millions of pounds. [More]
Researchers discover risk factors that contribute to fracture nonunion in adults

Researchers discover risk factors that contribute to fracture nonunion in adults

Dr. Robert Zura, the Robert D'Ambrosia Professor and Head of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of a research team that identified risk factors which may help orthopaedic surgeons better predict a serious complication of bone fractures. [More]
REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

A clinical decision rule (CDR) that can be applied to women after a first, unprovoked venous thromboembolism (VTE) was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016. [More]
New anticoagulant treatment safe and effective for AF patients before cardioversion

New anticoagulant treatment safe and effective for AF patients before cardioversion

Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a non-vitamin K antagonist (VKA) oral anticoagulant (NOAC), according to results of the ENSURE-AF trial. [More]
Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study. [More]
Alcohol-related hospitalisation linked to increased risk of ischaemic stroke in atrial fibrillation patients

Alcohol-related hospitalisation linked to increased risk of ischaemic stroke in atrial fibrillation patients

Alcohol related hospitalisation is associated with a doubled risk of ischaemic stroke risk in patients with non-valvular atrial fibrillation, according to a study presented at ESC Congress 2016 today by Dr Faris Al-Khalili, cardiologist, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden. [More]
First ESC Guidelines on Atrial Fibrillation published online

First ESC Guidelines on Atrial Fibrillation published online

The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) are published online today in European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and on the ESC Website. [More]
Updated AAN guidelines state closure not recommended for individuals with stroke and heart defect

Updated AAN guidelines state closure not recommended for individuals with stroke and heart defect

An updated recommendation from the American Academy of Neurology states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart. [More]
Hematology researchers develop new bio-engineered clotting factor to control bleeding

Hematology researchers develop new bio-engineered clotting factor to control bleeding

Every five minutes someone in the U.S. dies from a blood clot, through its role in strokes, heart attacks or other severe conditions. [More]
UNC professor identifies research priorities to address VTE in cancer patients

UNC professor identifies research priorities to address VTE in cancer patients

More than 20 percent of all blood clots in veins occur in cancer patients. These clots, also known as venous thromboembolism (VTE), pose serious threats for cancer patients. [More]
FDA approves new ExAblate Neuro to treat patients with essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. [More]
Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Firstly, a sample must be transported from the clinic to the laboratory. Simple tests may be undertaken in a small lab within the hospital or clinic, whilst complex testing such as drug susceptibility testing is often done in a large centralized laboratory many miles from the clinic [More]
Age no barrier to vorapaxar use in ACS

Age no barrier to vorapaxar use in ACS

The protease-activated receptor 1 inhibitor vorapaxar offers the same benefits to older and younger patients with non-ST segment elevation acute coronary syndromes, shows further analysis of the TRACER trial. [More]
Pioneering deck of cards created to support AF diagnosis and management in primary care

Pioneering deck of cards created to support AF diagnosis and management in primary care

A pioneering deck of cards created to support the diagnosis and management of Atrial Fibrillation (AF) in primary care is this week being launched across the North East and North Cumbria. [More]
Women less likely to receive good anticoagulant therapy for AF-related stroke, say researchers

Women less likely to receive good anticoagulant therapy for AF-related stroke, say researchers

Female atrial fibrillation patients are less likely than their male counterparts to receive blood thinning therapies to prevent stroke, say University of Cincinnati College of Medicine researchers. [More]
Trial results underestimate anticoagulant bleeding risk

Trial results underestimate anticoagulant bleeding risk

A study in The BMJ demonstrates that estimates of major bleeding risk in patients taking anticoagulants in clinical trials are unlikely to reflect the reality of clinical practice. [More]
Computerized decision support tool can assist physicians in prescribing stroke prevention therapy

Computerized decision support tool can assist physicians in prescribing stroke prevention therapy

Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision support tool that uses a combination of patient information and characteristics to assist physicians and patients with decisions about blood thinning treatment to prevent strokes in individuals with atrial fibrillation. [More]
Reasons for life-threatening blood clots in elite athletes

Reasons for life-threatening blood clots in elite athletes

Mary Cushman, M.D., M.Sc., a professor of medicine and director of the Thrombosis and Hemostasis Program at the University of Vermont, provides commentary on the causes of life-threatening blood clots in elite athletes. [More]
Advertisement
Advertisement